On the contrary, CAFs promote tumorigenesis in urothelial bladder carcinoma via multiple markers, including alpha smooth muscle actin, CD90/Thy-1, platelet-derived growth factor receptor-alpha and -beta (PDGFR-α/-β) and especially in advanced stages significantly increased FAP-expression [116]. This evidence concerns the gene THY1 and bladder transitional cell carcinoma.